Search tips
Search criteria 


Logo of aacPermissionsJournals.ASM.orgJournalAAC ArticleJournal InfoAuthorsReviewers
Antimicrob Agents Chemother. 1990 March; 34(3): 473–475.
PMCID: PMC171618

Inhibitory effects of 2'-fluorinated arabinosyl-pyrimidine nucleosides on woodchuck hepatitis virus replication in chronically infected woodchucks.


The treatment of woodchuck hepatitis virus infections with 1-(2'-deoxy-2'-fluoro-beta-D-arabinofuranosyl)-5-iodocytosine (FIAC) and 1-(2'-deoxy-2'-fluoro-beta-D-arabinofuranosyl)-5-methyluracil (FMAU), given intraperitoneally, caused complete and permanent decrease of serum virus endogenous DNA polymerase and viral DNA in all treated woodchucks but was associated with severe toxicity. By contrast 1-(2'-deoxy-2'-fluoro-beta-D-arabinofuranosyl)-5-ethyluracil (FEAU) induced a sustained, although less dramatic, decrease of viral replication without apparent toxic effect. FEAU was also effective when given orally. However, in both cases this inhibitory effect was transient.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (611K), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Images in this article

Click on the image to see a larger version.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Bellet DH, Wands JR, Isselbacher KJ, Bohuon C. Serum alpha-fetoprotein levels in human disease: perspective from a highly specific monoclonal radioimmunoassay. Proc Natl Acad Sci U S A. 1984 Jun;81(12):3869–3873. [PubMed]
  • Cova L, Hantz O, Arliaud-Gassin M, Chevalier A, Berthillon P, Boulay J, Jacquet C, Chomel B, Vitvitski L, Trepo C. Comparative study of DHBV DNA levels and endogenous DNA polymerase activity in naturally infected ducklings in France. J Virol Methods. 1985 Mar;10(3):251–260. [PubMed]
  • Dooley JS, Davis GL, Peters M, Waggoner JG, Goodman Z, Hoofnagle JH. Pilot study of recombinant human alpha-interferon for chronic type B hepatitis. Gastroenterology. 1986 Jan;90(1):150–157. [PubMed]
  • Frommel D, Crevat D, Vitvitsky L, Pichoud C, Hantz O, Chevalier M, Grimaud JA, Lindberg J, Trépo CG. Immunopathologic aspects of woodchuck hepatitis. Am J Pathol. 1984 Apr;115(1):125–134. [PubMed]
  • Galibert F, Chen TN, Mandart E. Nucleotide sequence of a cloned woodchuck hepatitis virus genome: comparison with the hepatitis B virus sequence. J Virol. 1982 Jan;41(1):51–65. [PMC free article] [PubMed]
  • Ganem D, Varmus HE. The molecular biology of the hepatitis B viruses. Annu Rev Biochem. 1987;56:651–693. [PubMed]
  • Gust ID, Burrell CJ, Coulepis AG, Robinson WS, Zuckerman AJ. Taxonomic classification of human hepatitis B virus. Intervirology. 1986;25(1):14–29. [PubMed]
  • Hantz O, Allaudeen HS, Ooka T, De Clercq E, Trepo C. Inhibition of human and woodchuck hepatitis virus DNA polymerase by the triphosphates of acyclovir, 1-(2'-deoxy-2'-fluoro-beta-D-arabinofuranosyl)-5-iodocytosine and E-5-(2-bromovinyl)-2'-deoxyuridine. Antiviral Res. 1984 Aug;4(4):187–199. [PubMed]
  • Hirota K, Sherker AH, Omata M, Yokosuka O, Okuda K. Effects of adenine arabinoside on serum and intrahepatic replicative forms of duck hepatitis B virus in chronic infection. Hepatology. 1987 Jan-Feb;7(1):24–28. [PubMed]
  • Hoofnagle JH, Hanson RG, Minuk GY, Pappas SC, Schafer DF, Dusheiko GM, Straus SE, Popper H, Jones EA. Randomized controlled trial of adenine arabinoside monophosphate for chronic type B hepatitis. Gastroenterology. 1984 Jan;86(1):150–157. [PubMed]
  • Nordenfelt E, Widell A, Hansson BG, Löfgren B, Möller-Nielsen C, Oberg B. No in vivo effect of trisodium phosphonoformate on woodchuck hepatitis virus production. Acta Pathol Microbiol Immunol Scand B. 1982 Dec;90(6):449–451. [PubMed]
  • Sherker AH, Hirota K, Omata M, Okuda K. Foscarnet decreases serum and liver duck hepatitis B virus DNA in chronically infected ducks. Gastroenterology. 1986 Oct;91(4):818–824. [PubMed]
  • Trépo C, Ouzan D, Fontanges T, Chevallier M, Chossegros P, Degos F, Chevallier P, Hantz O. Therapeutic activity of vidarabine in symptomatic chronic active hepatitis related to HBV. J Hepatol. 1986;3 (Suppl 2):S97–105. [PubMed]
  • Trépo C, Ouzan D, Fontanges T, Chevallier M, Chossegros P, Degos F, Chevallier P, Hantz O. Therapeutic potential of acyclovir and of the interferons in HBV-related chronic active hepatitis due to HBV with or without HDV superinfection. J Hepatol. 1986;3 (Suppl 2):S129–S135. [PubMed]
  • Venkateswaran PS, Millman I, Blumberg BS. Effects of an extract from Phyllanthus niruri on hepatitis B and woodchuck hepatitis viruses: in vitro and in vivo studies. Proc Natl Acad Sci U S A. 1987 Jan;84(1):274–278. [PubMed]
  • Yokosuka O, Omata M, Imazeki F, Hirota K, Mori J, Uchiumi K, Ito Y, Okuda K. Combination of short-term prednisolone and adenine arabinoside in the treatment of chronic hepatitis B. A controlled study. Gastroenterology. 1985 Aug;89(2):246–251. [PubMed]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)